Published in AIDS on January 28, 2000
Cytomegalovirus retinitis and the acquired immunodeficiency syndrome--bench to bedside: LXVII Edward Jackson Memorial Lecture. Am J Ophthalmol (2010) 1.31
Course of cytomegalovirus retinitis in the era of highly active antiretroviral therapy: five-year outcomes. Ophthalmology (2010) 1.04
2001 USPHS/IDSA guidelines for the prevention of opportunistic infections in persons infected with human immunodeficiency virus. Infect Dis Obstet Gynecol (2002) 0.90
Poor predictive value of cytomegalovirus (CMV)-specific T cell assays for the development of CMV retinitis in patients with AIDS. Clin Infect Dis (2008) 0.84
Lack of TNF-alpha promotes caspase-3-independent apoptosis during murine cytomegalovirus retinitis. Invest Ophthalmol Vis Sci (2011) 0.82
Effect of host genetics on the development of cytomegalovirus retinitis in patients with AIDS. J Infect Dis (2010) 0.81
HIV: primary and secondary prophylaxis for opportunistic infections. BMJ Clin Evid (2010) 0.79
Association of host genetic risk factors with the course of cytomegalovirus retinitis in patients infected with human immunodeficiency virus. Am J Ophthalmol (2011) 0.78
Canadian consensus guidelines for the management of cytomegalovirus disease in HIV/AIDS. Can J Infect Dis Med Microbiol (2004) 0.78
Is cytomegalovirus viraemia a useful tool in managing CMV disease? Sex Transm Infect (2000) 0.76
Cellular localization of human immunodeficiency virus infection within the brains of acquired immune deficiency syndrome patients. Proc Natl Acad Sci U S A (1986) 8.45
Cytomegalovirus infects human lymphocytes and monocytes: virus expression is restricted to immediate-early gene products. Proc Natl Acad Sci U S A (1984) 4.56
Detection of human cytomegalovirus in peripheral blood lymphocytes in a natural infection. Science (1985) 3.69
Posterior vitreoschisis. An echographic finding in proliferative diabetic retinopathy. Ophthalmology (1996) 2.70
Vision-threatening complications of surgery for full-thickness macular holes. Vitrectomy for Macular Hole Study Group. Ophthalmology (1997) 2.49
Brief report: uveitis caused by Tropheryma whippelii (Whipple's bacillus) N Engl J Med (1995) 2.47
Fas ligand-induced apoptosis of infected human macrophages reduces the viability of intracellular Mycobacterium tuberculosis. J Immunol (1998) 2.33
High-level resistance of cytomegalovirus to ganciclovir is associated with alterations in both the UL97 and DNA polymerase genes. J Infect Dis (1997) 2.14
Visual outcome in acute retinal necrosis. Retina (1993) 1.99
Localization of cytomegalovirus proteins and genome during fulminant central nervous system infection in an AIDS patient. J Neuropathol Exp Neurol (1986) 1.94
Propagation of antigen-specific T cell helper function in vitro. J Immunol (1979) 1.88
Retina and vitreous pathology after laser-assisted in situ keratomileusis: is there a cause-effect relationship? Ophthalmology (2001) 1.84
Correlation between CD4+ counts and prevalence of cytomegalovirus retinitis and human immunodeficiency virus-related noninfectious retinal vasculopathy in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1993) 1.82
Immune recovery vitritis associated with inactive cytomegalovirus retinitis: a new syndrome. Arch Ophthalmol (1998) 1.73
Lack of reactivation of cytomegalovirus (CMV) retinitis after stopping CMV maintenance therapy in AIDS patients with sustained elevations in CD4 T cells in response to highly active antiretroviral therapy. J Infect Dis (1998) 1.71
A prospective study of the ophthalmologic findings in the acquired immune deficiency syndrome. Am J Ophthalmol (1984) 1.70
Intravitreal cidofovir for the maintenance treatment of cytomegalovirus retinitis. Ophthalmology (1996) 1.66
Cytomegalovirus retinitis and response to therapy with ganciclovir. Ophthalmology (1987) 1.62
Prevalence, pathophysiology, and treatment of rhegmatogenous retinal detachment in treated cytomegalovirus retinitis. Am J Ophthalmol (1987) 1.58
Immune recovery vitritis and uveitis in AIDS: clinical predictors, sequelae, and treatment outcomes. Retina (2001) 1.53
Mutations in human cytomegalovirus UL97 gene confer clinical resistance to ganciclovir and can be detected directly in patient plasma. J Clin Invest (1995) 1.47
Visual dysfunction without retinitis in patients with acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 1.44
Intraocular tolerance of perfluorooctylbromide (perflubron) Retina (1995) 1.44
Exudative retinal detachment following grid laser photocoagulation in a patient with hemiretinal vein occlusion. Eur J Ophthalmol (2001) 1.39
Incidence of immune recovery vitritis in cytomegalovirus retinitis patients following institution of successful highly active antiretroviral therapy. J Infect Dis (1999) 1.39
Effects of induced electric fields on finite neuronal structures: a simulation study. IEEE Trans Biomed Eng (1993) 1.37
Suppression of epileptiform activity by high frequency sinusoidal fields in rat hippocampal slices. J Physiol (2001) 1.36
Confocal scanning infrared laser ophthalmoscopy for indocyanine green angiography. Am J Ophthalmol (1995) 1.35
Type-specific delayed hypersensitivity and protective immunity induced by isolated herpes simplex virus glycoprotein. J Immunol (1983) 1.34
Demonstration of herpes group virus in acute retinal necrosis syndrome. Am J Ophthalmol (1986) 1.33
Long-term posterior and anterior segment complications of immune recovery uveitis associated with cytomegalovirus retinitis. Am J Ophthalmol (2000) 1.33
Clinical failure of CMV retinitis with intravitreal cidofovir is associated with antiviral resistance. Arch Ophthalmol (1998) 1.29
Effects of applied electric fields on low-calcium epileptiform activity in the CA1 region of rat hippocampal slices. J Neurophysiol (2000) 1.29
Iritis and hypotony after treatment with intravenous cidofovir for cytomegalovirus retinitis. Arch Ophthalmol (1997) 1.28
Confocal laser tomographic analysis of the retina in eyes with macular hole formation and other focal macular diseases. Am J Ophthalmol (1989) 1.25
Treatment of cytomegalovirus retinitis with intravitreous cidofovir in patients with AIDS. A preliminary report. Ann Intern Med (1996) 1.24
Tolerance and suppression of immunity to herpes simplex virus: different presentations of antigens induce different types of suppressor cells. Infect Immun (1983) 1.23
Echographic localization of corticosteroids after periocular injection. Am J Ophthalmol (1987) 1.22
Analysis of visual dysfunctions in HIV-positive patients without retinitis. Am J Ophthalmol (1997) 1.22
Intravitreal properties of porous silicon photonic crystals: a potential self-reporting intraocular drug-delivery vehicle. Br J Ophthalmol (2008) 1.22
Suppression of natural killer cell activity and T cell proliferation by fresh isolates of human cytomegalovirus. J Infect Dis (1986) 1.22
Longitudinal study of cytomegalovirus retinitis in acquired immune deficiency syndrome. Ophthalmology (1990) 1.21
Gene transfer into stimulated and unstimulated T lymphocytes by HIV-1-derived lentiviral vectors. Gene Ther (2000) 1.20
Stochastic resonance improves signal detection in hippocampal CA1 neurons. J Neurophysiol (2000) 1.19
Optic neuropathy associated with cryptococcal arachnoiditis in AIDS patients. Am J Ophthalmol (1989) 1.17
Preemptive treatment approach to cytomegalovirus (CMV) infection in solid organ transplant patients: relationship between compliance with the guidelines and prevention of CMV morbidity. Transpl Infect Dis (2000) 1.16
Visual field loss in HIV-positive patients without infectious retinopathy. Am J Ophthalmol (1996) 1.16
Imaging the microvasculature of choroidal melanomas with confocal indocyanine green scanning laser ophthalmoscopy. Arch Ophthalmol (1998) 1.13
Recent clinical isolates of cytomegalovirus suppress human cytomegalovirus-specific human leukocyte antigen-restricted cytotoxic T-lymphocyte activity. J Virol (1986) 1.13
Synaptic noise improves detection of subthreshold signals in hippocampal CA1 neurons. J Neurophysiol (2001) 1.13
Role of CD40 ligand in Mycobacterium avium infection. Infect Immun (1999) 1.11
Morphometric comparisons of optic nerve axon loss in acquired immunodeficiency syndrome. Am J Ophthalmol (1992) 1.11
Discrepancies between MBC and actual killing of viridans group streptococci by cell-wall-active antibiotics. Antimicrob Agents Chemother (1986) 1.10
Ocular examination and diagnosis in patients with the acquired immunodeficiency syndrome. West J Med (1993) 1.10
Reconstruction of hippocampal CA1 pyramidal cell electrophysiology by computer simulation. J Neurophysiol (1994) 1.10
Selectivity of multiple-contact nerve cuff electrodes: a simulation analysis. IEEE Trans Biomed Eng (2001) 1.09
Pattern of early visual field loss in HIV-infected patients. Arch Ophthalmol (1999) 1.08
Wave-front generation of Zernike polynomial modes with a micromachined membrane deformable mirror. Appl Opt (1999) 1.07
Cytomegalovirus retinitis: a manifestation of the acquired immune deficiency syndrome (AIDS). Br J Ophthalmol (1983) 1.07
Suppression of axonal conduction by sinusoidal stimulation in rat hippocampus in vitro. J Neural Eng (2007) 1.04
Axial intensity distribution analysis of the human retina with a confocal scanning laser tomograph. Exp Eye Res (1994) 1.03
Influence of pulse sequence, polarity and amplitude on magnetic stimulation of human and porcine peripheral nerve. J Physiol (1998) 1.03
Oral fluorescein angiography with the confocal scanning laser ophthalmoscope. Ophthalmology (1999) 1.03
Modulation of burst frequency, duration, and amplitude in the zero-Ca(2+) model of epileptiform activity. J Neurophysiol (1999) 1.02
Prospective randomized trial of vitrectomy or observation for stage 2 macular holes. Vitrectomy for Macular Hole Study Group. Am J Ophthalmol (1996) 1.01
Automated scanning laser ophthalmoscope image montages of retinal diseases. Ophthalmology (1999) 1.01
New developments in the treatment of CMV retinitis. Ophthalmology (1996) 1.01
A graphical analysis of the interrelationships among waterborne asbestos, digestive system cancer and population density. Environ Health Perspect (1983) 1.01
Atypical healing of cytomegalovirus retinitis. Significance of persistent border opacification. Ophthalmology (1992) 1.01
Immune predispositions for cytomegalovirus retinitis in AIDS. The HNRC Group. J Clin Invest (1995) 1.01
Intraocular pressure and aqueous humor dynamics in patients with AIDS treated with intravitreal cidofovir (HPMPC) for cytomegalovirus retinitis. Am J Ophthalmol (1997) 1.01
Results of rhegmatogenous retinal detachment repair in cytomegalovirus retinitis with and without scleral buckling. Ophthalmology (1995) 1.01
Duration of vitrectomy and postoperative cataract in the vitrectomy for macular hole study. Am J Ophthalmol (2001) 1.00
A randomized, controlled study of intravenous ganciclovir therapy for cytomegalovirus peripheral retinitis in patients with AIDS. AIDS Clinical Trials Group and Cytomegalovirus Cooperative Study Group. J Infect Dis (1993) 1.00
AIDS-related optic neuropathy: a histological, virological and ultrastructural study. Graefes Arch Clin Exp Ophthalmol (1995) 0.99
Delayed hypersensitivity to herpes simplex virus: murine model. Infect Immun (1982) 0.99
Pattern electroretinograms and visual evoked potentials in HIV infection: evidence of asymptomatic retinal and postretinal impairment in the absence of infectious retinopathy. Neurology (1996) 0.99
Highly active antiretroviral therapy-related immune recovery in AIDS patients with cytomegalovirus retinitis. Ophthalmology (2000) 0.99
Lymphocyte subpopulations in uveitis. Arch Ophthalmol (1986) 0.98
Blind source separation of peripheral nerve recordings. J Neural Eng (2007) 0.98
Serum interleukin-6 (IL-6), IL-10, tumor necrosis factor (TNF) alpha, soluble type II TNF receptor, and transforming growth factor beta levels in human immunodeficiency virus type 1-infected individuals with Mycobacterium avium complex disease. J Clin Microbiol (2001) 0.98
Laser-tissue interaction and artifacts in confocal scanning laser ophthalmoscopy and tomography. Neurosci Biobehav Rev (1993) 0.97
Cytomegalovirus (CMV) retinitis activity is accurately reflected by the presence and level of CMV DNA in aqueous humor and vitreous. J Infect Dis (1999) 0.97
Visual dysfunction in HIV-positive patients without infectious retinopathy. AIDS Patient Care STDS (1998) 0.96
Intravitreal ganciclovir concentration after intravenous administration in AIDS patients with cytomegalovirus retinitis: implications for therapy. J Infect Dis (1993) 0.96
Retinal nerve fiber layer evaluation in human immunodeficiency virus-positive patients. Am J Ophthalmol (2001) 0.96
Rhegmatogenous retinal detachments in HIV-positive patients with ocular syphilis. Ophthalmic Surg Lasers (1996) 0.96
Bistability dynamics in simulations of neural activity in high-extracellular-potassium conditions. J Comput Neurosci (2001) 0.95
Vitrectomy surgery for full-thickness macular holes. Am J Ophthalmol (1993) 0.95
Long term visual outcome of patients with cytomegalovirus retinitis treated with highly active antiretroviral therapy. Br J Ophthalmol (2003) 0.94
Propagation of non-synaptic epileptiform activity across a lesion in rat hippocampal slices. J Physiol (2001) 0.94
Intravitreal toxicology in rabbits of two preparations of 1-O-octadecyl-sn-glycerol-3-phosphonoformate, a sustained-delivery anti-CMV drug. Invest Ophthalmol Vis Sci (1999) 0.94
A generalized cable equation for magnetic stimulation of axons. IEEE Trans Biomed Eng (1996) 0.94
Evaluation of microvascularization pattern visibility in human choroidal melanomas: comparison of confocal fluorescein with indocyanine green angiography. Graefes Arch Clin Exp Ophthalmol (1999) 0.94